Trevi Therapeutics News

Trevi Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144

Sep 12, 2023 04:05

Trevi Therapeutics | EFFECT: Others

Aug 16, 2023 12:15

Trevi Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144

Jun 13, 2023 04:47

Trevi Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144

Apr 11, 2023 23:44

Trevi Therapeutics | 424B5: Prospectus

Sep 24, 2022 05:22

Trevi Therapeutics | 424B5: Prospectus

Sep 23, 2022 04:06

Trevi Therapeutics | 424B5: Prospectus

May 14, 2022 06:27

Trevi Therapeutics | EFFECT: Others

May 12, 2022 12:15

Trevi Therapeutics | EFFECT: Others

Nov 17, 2021 13:15

Trevi Therapeutics | EFFECT: Others

Oct 26, 2021 12:15

Trevi Therapeutics | EFFECT: Others

Jul 15, 2021 12:15

Trevi Therapeutics | 424B3: Prospectus

Jul 15, 2021 05:05

Trevi Therapeutics | EFFECT: Others

Jul 6, 2020 12:15

Trevi Therapeutics | 424B3: Prospectus

Jul 3, 2020 04:26

Trevi Therapeutics | 424B4: Prospectus

May 9, 2019 04:02

Trevi Therapeutics | EFFECT: Others

May 8, 2019 12:16

Trevi Therapeutics | FWP: Filing under Securities Act Rules 163/433 of free writing prospectuses

May 8, 2019 01:32

Trevi Therapeutics | 8-A12B: Registration of a class of securities on a national securities exchange

Apr 29, 2019 22:32